Skip to main content

Share story

Security Products

ZuckOff app detects nearby camera glasses through Bluetooth signals

ZuckOff app detects nearby camera glasses through Bluetooth signals Image: Primary
Developer Pawel Szydlowski released ZuckOff, an app that scans Bluetooth broadcasts to flag nearby Ray-Ban Meta, Oakley Meta and Snap Spectacles camera glasses. He created device fingerprints by recording identifiers broadcast by hardware he purchased, and the app uses signal strength to estimate rough proximity. The app had more than 5,000 reported Apple App Store downloads in its launch month and 1,000 Google Play downloads when reviewed. Its central limitation is substantial: it cannot determine whether detected glasses are recording or identify their wearer, and some standalone models remain silent. Detection therefore indicates nearby compatible hardware, not active filming.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from wired.me and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...